This event marks the official launch of BEACON, a multidisciplinary program dedicated to advancing biomarker science for the early detection, risk assessment, and clinical management of cancer at Fred Hutch with cutting edge technologies and AI inspired tools.
Through expert-led panel discussions focused on emerging technologies, artificial intelligence, and clinical utility, this inaugural event will serve as a catalyst for forming a vibrant biomarker research community at Fred Hutch. Participants will have the opportunity to identify unmet needs in current biomarker research and shape the vision and set strategic priorities for the BEACON program.
Registration deadline is Thursday, May 29, 2025.
In-person:
Arnold Building
Behnke Suites M1-A305/307
Fred Hutch Cancer Center
1100 Fairview Ave. N.
Seattle, WA 98109
Free